Fig. 2From: Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive studyOutcomes (PNS symptoms and tumor responses) for patients diagnosed with a PNS before (cohort 1, left panel) or after (cohort 2, right panel) the initiation of immunotherapy. CR: Complete response. PR: Partial response. PNS: Paraneoplastic syndrome. PD: Progressive disease. SD: Stable diseaseBack to article page